Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TET2 | Q6N021 | 5/20 | 0.46 |
| ▸ | TET3 | O43151 | 1/20 | 0.46 |
| ▸ | TET1 | Q8NFU7 | 1/20 | 0.46 |
| ▸ | GRIK1 | P39086 | 1/20 | 0.45 |
| ▸ | GRIK2 | Q13002 | 1/20 | 0.45 |
| ▸ | GRM1 | Q13255 | 1/20 | 0.45 |
| ▸ | GRM2 | Q14416 | 1/20 | 0.45 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6064308 | 0.81 | TET2 (0.50) | TET2TET3TET1GRIK1GRIK2 | |
| SCHEMBL6063635 | 0.79 | TET2 (0.48) | TET2TET3TET1GRIK1GRIK2 | |
| SCHEMBL6064272 | 0.77 | TET2 (0.46) | TET2TET3TET1GRIK1GRIK2 | |
| SCHEMBL2966907 | 0.75 | — | — | |
| SCHEMBL1995655 | 0.71 | TET2 (0.56) | TET2TET3TET1GRIK1GRIK2 | |
| SCHEMBL2001779 | 0.71 | TET2 (0.56) | TET2TET3TET1GRIK1GRIK2 | |
| SCHEMBL1995657 | 0.71 | TET2 (0.56) | TET2TET3TET1GRIK1GRIK2 | |
| SCHEMBL6063566 | 0.71 | TET2 (0.45) | TET2TET3TET1GRIK1GRIK2 | |
| SCHEMBL11037132 | 0.67 | TET2 (0.64) | TET2TET3TET1GRIK1GRIK2 | |
| SCHEMBL2158348 | 0.67 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7148363-B2 | Process for preparing acrylate compound | TOSOH CORPORATION (JP) | 2006-12-12 | — | — | US | disclosed |
| US-20050148789-A1 | Process for preparing acrylate compound | TOSOH CORPORATION | 2005-07-07 | — | — | US | disclosed |
| US-6833462-B2 | Esterification to get cyclic acrylate compounds; used as raw material for functional polymers, pharmaceuticals, pesticides, semiconductor lithography | TOSOH CORPORATION (JP) | 2004-12-21 | — | — | US | disclosed |
| US-20030139613-A1 | Process for preparing acrylate compound | TOSOH CORPORATION | 2003-07-24 | — | — | US | disclosed |
| US-5612281-A | Recording sheet | FUJI PHOTO FILM CO., LTD. (JP) | 1997-03-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030139613-A1 | Process for preparing acrylate compound | AFF1, AFF4, RER1 | TET2 1456/4885TET3 2642/4885TET1 2849/4885 |
| US-20050148789-A1 | Process for preparing acrylate compound | ACR, AFF4, AFF1 | TET2 1202/4885TET3 2886/4885TET1 3338/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.